- Home
- BIO vs ACM Comparison
BIO vs ACM Comparison
Compare BIO & ACM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIO | ACM |
|---|---|---|
| Founded | 1952 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.7B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BIO | ACM |
|---|---|---|
| Price | $357.53 | $62.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $339.75 | $131.30 |
| AVG Volume (30 Days) | 293.3K | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ 142.61 | 42.71 |
| EPS | N/A | ★ 1.29 |
| Revenue | $2,583,200,000.00 | ★ $16,139,622,000.00 |
| Revenue This Year | $2.74 | N/A |
| Revenue Next Year | $3.20 | $6.06 |
| P/E Ratio | ★ N/A | $49.31 |
| Revenue Growth | ★ 0.65 | 0.21 |
| 52 Week Low | $236.73 | $60.35 |
| 52 Week High | $365.00 | $135.52 |
Technical Indicators
Market Signals| Indicator | BIO | ACM |
|---|---|---|
| Relative Strength Index (RSI) | 72.62 | 35.41 |
| Support Level | $289.16 | N/A |
| Resistance Level | N/A | $72.43 |
| Average True Range (ATR) | 12.24 | 2.68 |
| MACD | 2.07 | -1.32 |
| Stochastic Oscillator | 85.10 | 14.43 |
Price Performance
Historical ComparisonAbout BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About ACM AECOM
Aecom is one of the largest global providers of advisory, design, and engineering services. It serves a broad spectrum of end markets, including water, transportation, and environment. Based in Dallas, Aecom employs 51,000 people. The company generated $16.1 billion in sales in fiscal 2025.